Diagnostics

Veritas Genetics announces myGenome, the world’s first whole genome test for less than $1,000

Other commercial tests only explore a small portion of the genome with gene panels – myGenome would essentially replace the need for any of those individually.

Veritas myGenome

Veritas Genetics, co-founded by Harvard Medical School professor and genetics pioneer Dr. George Church, announced Thursday at Scripps’ the Future of Genomic Medicine conference the introduction of myGenome – the first whole genome test for less than $1000.

myGenome is unique because of its all encompassing level of information but also because it comes with genetic counseling via video counseling so that results can be accurately assessed instead of leaving that up to the consumer or a physician.

Other commercial tests only explore a small portion of the genome with gene panels – myGenome would essentially replace the need for any of those individually.

As CEO and co-founder Mizra Cifric explained in an interview at the conference, what companies like 23andMe are doing is “interesting,” but doesn’t come close to the information you get from looking at the entire genome, which he says is the foundation of precision medicine.

Veritas first made whole genome sequencing available to 5,000 participants with its Personal Genome Project (PGP) at Harvard Medical School.

The platform will now allow patients to have access to physicians (due to a partnership with WorldCare International and WorldCare Consortium) at Massachusetts General Hospital, Dana Farber Cancer Institute, Boston Children’s Hospital, Mayo Clinic and others to use the information gathered and get clinical feedback.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

myGenome is now available for pre-order.